Ticker Details
LivaNova PLC Ordinary Shares LivaNova PLC is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation.
IPO Date:	October 19, 2015
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$3.47B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.93 | 1.46%
Avg Daily Range (30 D):	$0.79 | 1.24%
Avg Daily Range (90 D):	$0.79 | 1.24%

Institutional Daily Volume
Avg Daily Volume:	.41M
Avg Daily Volume (30 D):	.68M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	50

Institutional Trades
Total Institutional Trades:	6,715
Avg Institutional Trade:	$2.51M
Avg Institutional Trade (30 D):	$3.52M
Avg Institutional Trade (90 D):	$3.42M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.44M
Avg Closing Trade (30 D):	$7.47M
Avg Closing Trade (90 D):	$6.73M
Avg Closing Volume:	56.22K

News

Mar 27, 2026 @ 2:15 PM MedTech's Edge: How AI and Remote Diagnostics Driv... Source: Equity Insider

Feb 23, 2026 @ 6:00 PM Global Neuromodulation Devices Market Anticipating... Source: Delveinsight

Jan 26, 2026 @ 1:32 AM From Humanoid Robots to AI Seating: VivaNova Debut... Source: Not Specified

Jan 13, 2026 @ 12:00 PM Extracorporeal Membrane Oxygenation Machine Market... Source: Sns Insider

Feb 20, 2025 @ 8:30 AM Global Magnetic Ablation Catheters Market Poised f... Source: Future Market Insights, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-4.45	$.56	$-4.45
Diluted EPS	$-4.45	$.56	$-4.45
Revenue	$1.39B	$360.92M	$1.39B
Gross Profit	$939.87M	$239.77M	$939.87M
Net Income / Loss	$-242.47M	$30.91M	$-242.47M
Operating Income / Loss	$199.39M	$42.58M	$199.39M
Cost of Revenue	$448.18M	$121.15M	$448.18M
Net Cash Flow	$-88M	$-10.53M	$-88M
PE Ratio